Short answer
Ardent Health, Inc. (ARDT) filed its Q3 2026 10-Q quarterly report on Nov 5, 2026 for the quarter ended Sep 30, 2026. Quarterly revenue was $1.6B (up 3.1% year over year) with net income of $45M.
Q3 2026 key financials · XBRL
- Revenue
- $1.6B
- +3.1% YoY · +0.2% QoQ
- Net income
- $45M
- +289.6% YoY · +163.4% QoQ
- EPS (diluted)
- $0.31
- +282.4% YoY · +158.3% QoQ
Source: XBRL data from the Ardent Health, Inc. (ARDT) Q3 2026 10-Q on SEC EDGAR. USD.
Ardent Health, Inc. Q3 2026 10-Q analysis
AI summary of MD&A and risk factor updates
Management Discussion & Analysis
- Revenue $1,624.9M, up $48.1M or 3.1% YoY, driven by adjusted admissions growth of 2.9%
- Net income attributable to Ardent $44.5M, margin 2.7% vs negative 1.5% YoY
- Medicaid supplemental payments $156.9M vs $186.5M YoY, the primary revenue headwind
- Cash $766.2M and available liquidity $1,009.8M at September 30, 2026
- Operating cash flow $258.4M vs $247.1M YoY, with $115.6M capital expenditures and $24.0M share repurchases year-to-date
Risk Factors
- No material changes to previously disclosed risk factors in the Annual Report
- Regulatory, legal, and compliance risks remain those identified in the Annual Report
- Operational and competitive risks remain those identified in the Annual Report
- Liquidity, debt, currency, and concentration risks remain those identified in the Annual Report
Generated from the filing text; verify against the original. 10-K vs 10-Q vs 8-K
Other Ardent Health, Inc. quarterly reports
Ask about this quarter
Compare quarters, check guidance or see what insiders and funds did around the report.